NCT06348082 (Project WISHES) is a NA clinical trial of Mindfulness-based therapy for insomnia (MBTI) in Insomnia, sponsored by Yale University.

Who is sponsoring NCT06348082?

NCT06348082 is sponsored by Yale University.

What drugs are being tested in NCT06348082?

Interventions in NCT06348082: Mindfulness-based therapy for insomnia (MBTI).

What condition does NCT06348082 study?

NCT06348082 studies Insomnia, Sleep Health, Cardiometabolic Health.

Is NCT06348082 still recruiting?

NCT06348082 is currently recruiting now. Last updated 19 February 2026.

Last reviewed 2026-02-19 · How we verify

NCT06348082: Project WISHES

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Project Women's Insomnia Sleep Health Equity Study (WISHES)

Recruiting now NA Last updated 19 February 2026

What this trial tests

NA trial testing Mindfulness-based therapy for insomnia (MBTI) in Insomnia in 340 participants. Currently enrolling.

Timeline

6 January 2026

Primary endpoint
1 July 2028

31 August 2028

Quick facts

Lead sponsor	Yale University
Phase	NA
Status	Recruiting now
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	quadruple
Primary purpose	supportive care
Enrollment	340
Start date	6 January 2026
Primary completion	1 July 2028
Estimated completion	31 August 2028
Sites	2 locations across United States

Drugs / interventions tested

Mindfulness-based therapy for insomnia (MBTI)

Conditions studied

Insomnia — all drugs for Insomnia →
Sleep Health — all drugs for Sleep Health →
Cardiometabolic Health — all drugs for Cardiometabolic Health →

Sponsor

Yale University

Who can join

Adults 18 to 70, female only, with Insomnia or Sleep Health. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study is to achieve health and healthcare equity by implementing an equity-focused, mindfulness-based sleep intervention to reduce stress and sleep deficiency-related cardiometabolic disease burden in Black women.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Protocol for a hybrid type 1 effectiveness-implementation study of mindfulness-based therapy for insomnia in Black women.
Nam S, Tong G, Iennaco J, Humphries D, et al · · 2026 · PMID 41308952 · DOI 10.1016/j.cct.2025.108166

Verify or expand the search:

Other trials of Mindfulness-based therapy for insomnia (MBTI)

Trials testing the same drug.

NCT04951466 — Mindfulness Based Therapy for Insomnia in Black Women · NA · completed

Other recruiting trials for Insomnia

Currently open trials in the same condition.

NCT07384429 — Effects of Lemborexant on Motor-sleep Comorbidity in Parkinson's Disease · Phase 4 · recruiting
NCT07270406 — Healthy Behaviors for Insomnia Prevention in People With HIV and Ongoing Pain · NA · recruiting
NCT07071324 — CF Wellness Program · NA · recruiting
NCT07417813 — A Multicenter Observational Study of Lemborexant on Insomnia Patients With Psychiatric Disorders · recruiting
NCT07345065 — Sleep-MOMagement: Improving Postpartum Sleep in First-time Mothers Through Tailored Behavioral Approaches. · NA · recruiting

Other Yale University trials

Trials by the same sponsor.

NCT06900998 — Pilot Study: Effects of Nimodipine on Alcohol Drinking · Phase 2 · not yet recruiting
NCT04910984 — Developing a Chatbot to Promote HIV Testing · NA · not yet recruiting
NCT07458087 — Accuracy of the Accuro 3S · NA · not yet recruiting
NCT07398404 — A Multiple Health Behavior Change (MHBC) Intervention for Weight Loss and Smoking Cessation for Pre-Bariatric Surgery Pa · Phase 1, PHASE2 · not yet recruiting
NCT07305324 — Improving Liver Fibrosis Diagnosis in Primary Care Using FibroX AI · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06348082 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 9 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Yale University
Last refreshed: 19 February 2026

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06348082.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing